Pharmacodynamic Modeling of Vecuronium‐induced Twitch Depression: Rapid Plasma‐Effect Site Equilibration Explains Faster Onset at Resistant Laryngeal Muscles than at the Adductor Pollicis

Background After bolus doses of nondepolarizing muscle relaxants, the adductor pollicis recovers from paralysis more slowly than the diaphragm and the laryngeal adductors, suggesting that the adductor pollicis is more sensitive than the respiratory muscles to effects of those drugs. In contrast, during onset, the respiratory muscles are paralyzed more rapidly than the adductor pollicis, suggesting that the respiratory muscles are more sensitive than the adductor pollicis. To reconcile these apparently conflicting findings, we determined vecuronium's pharmacokinetics and its pharmacodynamics at both the adductor pollicis and the laryngeal adductors. Methods Six volunteers were studied on two occasions during anesthesia with propofol. Mechanical responses to train‐of‐four stimulation were measured at the adductor pollicis and at the laryngeal adductors. Vecuronium (15–60 micro gram/kg) was given and arterial plasma samples were obtained from 0.5–60 min. Vecuronium doses differed by twofold on the two occasions. A pharmacokinetic model accounting for the presence and potency of vecuronium's 3‐desacetyl metabolite and a sigmoid e‐max pharmacodynamic model were fit to the resulting plasma concentration and effect (adductor pollicis and laryngeal adductors) data to determine relative sensitivities and rates of equilibration between plasma and effect site concentrations. Results The steady‐state plasma concentration depressing laryngeal adductor twitch tension by 50% was approximately 1.5 times larger than that for the adductor pollicis. The equilibration rate constant between plasma and laryngeal adductor concentrations was about 1.5 faster than that between plasma and adductor pollicis concentrations. The Hill factor (gamma) that describes the steepness of the laryngeal adductor concentration‐effect relation was approximately 0.6 times that of the adductor pollicis. Conclusions More rapid equilibration between plasma and laryngeal adductor vecuronium concentrations explains why onset is more rapid at the laryngeal adductors than at the adductor pollicis. During recovery, both rapid equilibration and lesser sensitivity of the laryngeal adductors contribute to earlier recovery.

[1]  C. Meistelman,et al.  Mivacurium Neuromuscular Block at the Adductor Muscles of the Larynx and Adductor Pollicis in Humans , 1996, Anesthesiology.

[2]  J H Proost,et al.  Pharmacokinetics and pharmacodynamics of rocuronium at the vocal cords and the adductor pollicis in humans , 1995, Clinical pharmacology and therapeutics.

[3]  Ronald D. Miller,et al.  Onset and Duration of Rocuronium and Succinylcholine at the Adductor Pollicis and Laryngeal Adductor Muscles in Anesthetized Humans , 1994, Anesthesiology.

[4]  R. Miller,et al.  The pharmacodynamics and pharmacokinetics of the metabolite 3-desacetylvecuronium (ORG 7268) and its parent compound, vecuronium, in human volunteers. , 1994, The Journal of pharmacology and experimental therapeutics.

[5]  C. Meistelman,et al.  Comparison of Twitch Depression of the Adductor Pollicis and the Respiratory Muscles Pharmacodynamic Modeling without Plasma Concentrations , 1994, Anesthesiology.

[6]  F. Donati,et al.  Importance of Early Blood Sampling on Vecuronium Pharmacokinetic and Pharmacodynamic Parameters , 1993, Clinical pharmacokinetics.

[7]  C. Meistelman,et al.  Neuromuscular Effects of Succinylcholine on the Vocal Cords and Adductor Pollicis Muscles , 1991, Anesthesia and analgesia.

[8]  C. Meistelman,et al.  A method to measure elicited contraction of laryngeal adductor muscles during anesthesia. , 1991, Anesthesiology.

[9]  C. Meistelman,et al.  Vecuronium neuromuscular blockade at the adductor muscles of the larynx and adductor pollicis. , 1991, Anesthesiology.

[10]  C. Meistelman,et al.  Vecuronium neuromuscular blockade at the diaphragm, the orbicularis oculi, and adductor pollicis muscles. , 1990, Anesthesiology.

[11]  L B Sheiner,et al.  Simultaneous modeling of pharmacokinetics and pharmacodynamics with nonparametric kinetic and dynamic models , 1986, Clinical pharmacology and therapeutics.

[12]  D. Newton,et al.  Rate of onset of good intubating conditions, respiratory depression and hand muscle paralysis after vecuronium. , 1984, British journal of anaesthesia.

[13]  Lewis B. Sheiner,et al.  Simultaneous modeling of pharmacokinetics and pharmacodynamics: Application to d‐tubocurarine , 1979 .

[14]  R. Miller,et al.  Quantitation of pancuronium, 3-desacetylpancuronium, vecuronium, 3-desacetylvecuronium, pipecuronium and 3-desacetylpipecuronium in biological fluids by capillary gas chromatography using nitrogen-sensitive detection. , 1988, Journal of chromatography.